Overview

Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia

Status:
Completed
Trial end date:
2018-08-22
Target enrollment:
Participant gender:
Summary
To assess the efficacy of a closed loop glucagon system to prevent and treat hypoglycemia occurring in patients with Post-Bariatric Hypoglycemia (PBH) in response to meals and exercise.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Joslin Diabetes Center
Collaborators:
Harvard University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
Xeris Pharmaceuticals
Treatments:
Glucagon
Glucagon-Like Peptide 1